Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism
<p><strong>Objective:</strong> Increased hepatic de novo lipogenesis (DNL) is suggested to be an underlying cause in the development of non-alcoholic fatty liver disease (NAFLD) and/or insulin resistance. It is suggested that the omega-3 fatty acids (FA) lower hepatic DNL. We inves...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020
|